GNTA logo

Genenta Science SpA (GNTA) Company Overview

Profile

Full Name:

Genenta Science S.p.A.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Italy

IPO:

December 15, 2021

Indexes:

Not included

Website:

http://www.genenta.com

Description:

Genenta Science SpA is a biotechnology company focused on developing innovative gene therapies for cancer treatment. They use a unique approach to deliver therapeutic genes directly to patients' immune cells, aiming to enhance the body's ability to fight tumors and improve patient outcomes.

Key Details

Price

$3.71

Market Cap

$67.86 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.69(-39.78% YoY)

PE Ratio

-

Annual ROE

-55.82%

Annual Debt To Equity

0.00

Beta

-0.14

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Apr 26, 2023

Recent annual earnings:

Apr 26, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 2, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Feb 8, 23 HC Wainwright & Co.
Buy
Jan 5, 23 EF Hutton
Buy
Jul 25, 22 HC Wainwright & Co.
Buy
Jan 13, 22 Maxim Group
Buy

Screeners with GNTA included

Growing Shares Outstanding
Stocks below SMA 200
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks with low beta
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.71
GNTA price is $3.71

Price All-time High

$11.87
GNTA price is currently -68.74% below its historical high of $11.87

Price Analysts Target

-
GNTA price consensus analysts' forecast is unknown

Price Most Recent Change

-4.87%
GNTA price was down -4.87% on Mar 3, 2025

Price YTD Change

-14.71%
GNTA price is down -14.71% since January 1st

Price 3-Year Change

-46.23%
GNTA price is down -46.23% over the past 3 years

Market cap

Market Cap

$67.86 M
GNTA market capitalization is $67.86 million

Market Cap 3-Year Change

-46.02%
GNTA market capitalization is down -46.02% over the past 3 years

Market Cap All-time High

$215.09 M
GNTA market capitalization is currently -68.45% below its historical high of $215.09 million

Market Cap Sector Rank

40.33%
GNTA market capitalization is higher than 40.33% of companies in Healthcare sector

Technical

Beta

-0.14
GNTA beta is -0.14

200-day SMA

$4.24
GNTA price is currently -12.54% below its 200-day simple moving average

14-day RSI

41.80
GNTA 14-day relative strength index is 41.80

30-day Relative Volume

0.55
GNTA 30-day relative volume is 0.55

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
GNTA annual revenue value is unknown

Annual Revenue Analysts Estimate

-
GNTA annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
GNTA annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
GNTA annual revenue is unknown

Profit

Annual Gross Profit

-
GNTA annual gross profit value is unknown

Annual Gross Margin

-
GNTA annual gross profit margin value is unknown

Annual Operating Profit

-$12.70 M
GNTA annual operating income is -$12.70 million

Annual Operating Margin

-
GNTA annual operating profit margin value is unknown

Annual Net Income

-$12.61 M
GNTA annual net profit is -$12.61 million

Annual Net Margin

-
GNTA annual net profit margin value is unknown

EPS

Annual EPS

-$0.69
GNTA annual earnings per share is -$0.69

Annual EPS Analysts Estimate

-$0.65
GNTA annual earnings per share is currently +6.60% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-39.78%
GNTA annual earnings per share is down -39.78% year-on-year

Annual EPS Sector Rank

65.83%
GNTA annual earnings per share is higher than 65.83% of companies in Healthcare sector

ROA & ROE

Annual ROA

-51.04%
GNTA annual return on assets is -51.04%

Annual ROE

-55.82%
GNTA annual return on equity is -55.82%

EBIT & EBITDA

Annual EBIT

-$12.70 M
GNTA annual earnings before interest & taxes is -$12.70 million

Annual EBITDA

-$12.66 M
GNTA annual EBITDA is -$12.66 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
GNTA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
GNTA price to earnings ratio is unknown

PB Ratio

PB Ratio

3.76
GNTA price to book ratio is 3.76

PB Ratio Sector Rank

75.41%
GNTA price to book ratio is higher than 75.41% of companies in Healthcare sector

PS Ratio

PS Ratio

-
GNTA price to sales ratio value is unknown

PS Ratio Sector Rank

-
GNTA price to sales ratio is unknown

Enterprise value

Enterprise Value

$61.22 M
GNTA enterprise value is $61.22 million

Enterprise Value Sector Rank

42.67%
GNTA enterprise value is higher than 42.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GNTA EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
GNTA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

12.25
GNTA annual current ratio is 12.25

Annual Quick Ratio

-
GNTA annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
GNTA annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
GNTA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GNTA piotroski f-score value is unknown

Altman Z-Score

-
GNTA altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$24.70 M
GNTA annual total assets is $24.70 million

Annual Non Current Assets

$1.21 M
GNTA annual long term assets is $1.21 million

Annual Current Assets

$23.50 M
GNTA annual total current assets is $23.50 million

Annual Cash & Cash Equivalents

$4.08 M
GNTA annual cash & cash equivalents is $4.08 million

Equity

Annual Book Value

$22.59 M
GNTA annual book value is $22.59 million

Annual Working Capital

$21.58 M
GNTA annual working capital is $21.58 million

Liabilities

Annual Total Liabilities

$2.12 M
GNTA annual total liabilities is $2.12 million

Annual Total Long Term Liabilities

$198.10 K
GNTA annual total long term liabilities is $198.10 thousand

Annual Current Liabilities

$1.92 M
GNTA annual total current liabilities is $1.92 million

Annual Accounts Payable

$326.10 K
GNTA annual accounts payable is $326.10 thousand

Debt

Annual Total Debt

$0.00
GNTA annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
GNTA {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
GNTA annual long term debt value is unknown

Annual Short Term Debt

-
GNTA annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$12.70 M
GNTA annual total expenses is $12.70 million

Annual Operating Expenses

$12.70 M
GNTA annual total operating expenses is $12.70 million

Annual Cost Of Goods Sold

-
GNTA annual cost of goods sold value is unknown

Annual SGA

$5.69 M
GNTA annual SGA is $5.69 million

Annual D&A

$46.00 K
GNTA annual depreciation & amortization is $46.00 thousand

Annual Interest Expense

-
GNTA annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$12.13 M
GNTA annual cash flow from operations is -$12.13 million

Annual CFO 1-Year Change

-55.06%
GNTA annual cash flow from operations is down -55.06% year-on-year

Annual CFI

-$16.12 M
GNTA annual cash flow from investing activities is -$16.12 million

Annual CFI 1-Year Change

-56471.58%
GNTA annual cash flow from investing activities is down -56471.58% year-on-year

Annual CFF

$600.00
GNTA annual cash flow from financing activities is $600.00

Annual CFF 1-Year Change

+100%
GNTA annual cash flow from financing activities is up +100% year-on-year

Free CashFlow

Annual FCF

-$12.15 M
GNTA annual free cash flow is -$12.15 million

Annual FCF 1-Year Change

-54.69%
GNTA annual free cash flow is down -54.69% year-on-year

CAPEX

Annual CAPEX

-
GNTA annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
GNTA annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

HYPR logo
Hyperfine (HYPR)
BYSI logo
BeyondSpring (BYSI)
PMVP logo
PMV Pharmaceuticals (PMVP)
Artiva Biotherapeutics (ARTV)
MASS logo
908 Devices (MASS)
INO logo
Inovio Pharmaceuticals (INO)
PYXS logo
Pyxis Oncology (PYXS)
TARA logo
Protara Therapeutics (TARA)
ZIVO logo
ZIVO Bioscience (ZIVO)

FAQ

  • What is the ticker symbol for Genenta Science SpA?
  • Does Genenta Science SpA pay dividends?
  • What sector is Genenta Science SpA in?
  • What industry is Genenta Science SpA in?
  • What country is Genenta Science SpA based in?
  • When did Genenta Science SpA go public?
  • Is Genenta Science SpA in the S&P 500?
  • Is Genenta Science SpA in the NASDAQ 100?
  • Is Genenta Science SpA in the Dow Jones?
  • When was Genenta Science SpA's last earnings report?
  • When does Genenta Science SpA report earnings?

What is the ticker symbol for Genenta Science SpA?

The ticker symbol for Genenta Science SpA is NASDAQ:GNTA

Does Genenta Science SpA pay dividends?

No, Genenta Science SpA does not pay dividends

What sector is Genenta Science SpA in?

Genenta Science SpA is in the Healthcare sector

What industry is Genenta Science SpA in?

Genenta Science SpA is in the Biotechnology industry

What country is Genenta Science SpA based in?

Genenta Science SpA is headquartered in Italy

When did Genenta Science SpA go public?

Genenta Science SpA's initial public offering (IPO) was on December 15, 2021

Is Genenta Science SpA in the S&P 500?

No, Genenta Science SpA is not included in the S&P 500 index

Is Genenta Science SpA in the NASDAQ 100?

No, Genenta Science SpA is not included in the NASDAQ 100 index

Is Genenta Science SpA in the Dow Jones?

No, Genenta Science SpA is not included in the Dow Jones index

When was Genenta Science SpA's last earnings report?

Genenta Science SpA's most recent earnings report was on Apr 26, 2023

When does Genenta Science SpA report earnings?

The date for Genenta Science SpA's next earnings report has not been announced yet